跳至主要内容
临床试验/TCTR20211017001
TCTR20211017001尚未招募3 期

A comparative study of the effectiveness between pulse regimen methylprednisolone versus high dose dexamethasone as the initial treatment of moderate Covid-19 pneumonia: An open-label randomized controlled trial

Faculty of Medicine Ramathibodi Hospital0 个研究点目标入组 120 人开始时间: 2021年10月17日最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 N/A (No limit)(—)
性别
All

入选标准

  • 1. Age over 18 years old
  • 2. Visited within 48 hours
  • 3. Respiratory sample was confirmed Covid-19 by RT-PCR
  • 4. Evidence of pneumonia by chest imaging
  • 5. Resting oxygen saturation between 90-94%
  • 6. Voluntary consent

排除标准

  • 1. Recieved high flow nasal cannula, non-invasive mechanical ventilation or invasive mechanical ventilation
  • 2. High risk for cortiosteroid such as current active infection or poor glycemic control
  • 3. Immunocompromised host such as end stage liver disease, end stage renal disease without renal replacement therapy, HIV CD4 less than 200 or cancer with on going chemotherapy
  • 4. Pregnant women
  • 5. Psychiatric problems
  • 6. Current use of corticosteroid (more than 20 mg of prednisolone equivalent dose and consecutively more than 14 day)

研究者

发起方
Faculty of Medicine Ramathibodi Hospital

相似试验

A comparative study of the effectiveness between... | 临床试验